Quercetin 3-(beta-D-glucofuranoside) Uses, Dosage, Side Effects and more
Quercetin 3-(beta-D-glucofuranoside) is under investigation in clinical trial NCT04622865 (Masitinib Combined With Isoquercetin and Best Supportive Care in Hospitalized Patients With Moderate and Severe COVID-19).
| Attribute | Details |
|---|---|
| Trade Name | Quercetin 3-(beta-D-glucofuranoside) |
| Generic | Isoquercitrin |
| Isoquercitrin Other Names | Isoquercetin enzymatically modified, Isoquercitroside, Isotrifoliin, Isotrifolin, Quercetin 3-(beta-D-glucofuranoside) |
| Type | |
| Formula | C21H20O12 |
| Weight | Average: 464.379 Monoisotopic: 464.095476084 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
